Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9OKI

Cryo-EM structure of human SV2A in complex with UCBJ and UCB1244283

これはPDB形式変換不可エントリーです。
9OKI の概要
エントリーDOI10.2210/pdb9oki/pdb
EMDBエントリー70565
分子名称Synaptic vesicle glycoprotein 2A, (4R)-1-[(3-methylpyridin-4-yl)methyl]-4-(3,4,5-trifluorophenyl)pyrrolidin-2-one, (3S)-4-(3,5-dimethylphenyl)-N-(2-methoxyphenyl)-3-methylbutanamide (3 entities in total)
機能のキーワードslc transporter, slc22 family, membrane protein, inhibitor
由来する生物種Homo sapiens
タンパク質・核酸の鎖数1
化学式量合計68453.89
構造登録者
Pidathala, S.,Dai, Y.,Lee, C.H. (登録日: 2025-05-09, 公開日: 2025-12-10)
主引用文献Pidathala, S.,Chen, X.,Dai, Y.,Nguyen, L.N.,Gorgulla, C.,Niu, Y.,Liu, F.,Lee, C.H.
Structural pharmacology of SV2A reveals an allosteric modulation mechanism in the major facilitator superfamily.
Nat Commun, 16:10748-10748, 2025
Cited by
PubMed Abstract: The synaptic vesicle glycoprotein 2A (SV2A), a member of the major facilitator superfamily (MFS), is a key target for antiseizure medications and a biomarker for synaptic density imaging. Despite its clinical importance, the mechanisms underlying SV2A ligand binding and modulation remain poorly understood. Here, we report sub-3 Å resolution cryo-electron microscopy (cryo-EM) structures of human SV2A in its apo form and in complex with FDA-approved antiseizure medication levetiracetam; PET imaging tracer UCB-J; experimental antiseizure drug padsevonil; and allosteric modulator UCB1244283. We find that levetiracetam and UCB-J induce vestibule occlusion, a hallmark conformational transition of MFS transporters that had not been observed in previous SV2A structures. UCB1244283 binds to an allosteric site and enhances orthosteric ligand engagement by stabilizing the occluded state and slowing ligand dissociation. Notably, padsevonil occupies both orthosteric and allosteric sites, functionally precluding modulation. These findings uncover an allosteric mechanism of regulation and provide a structural framework for the development of modulators targeting SV2A and related MFS transporters.
PubMed: 41315229
DOI: 10.1038/s41467-025-65781-1
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.67 Å)
構造検証レポート
Validation report summary of 9oki
検証レポート(詳細版)ダウンロードをダウンロード

247947

件を2026-01-21に公開中

PDB statisticsPDBj update infoContact PDBjnumon